{"id":"c87bfb80-eec9-5f13-a8c7-e7585737f46f","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-mevalonate-not-cholesterol-trains","predicate":"causes","statement":"Activation of the cholesterol synthesis pathway but not the synthesis of cholesterol itself is essential for training of myeloid cells, rather the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways, statins which block mevalonate generation prevent trained immunity induction, and monocytes of patients with hyper immunoglobulin D syndrome who are mevalonate kinase deficient and accumulate mevalonate have a constitutive trained immunity phenotype at both immunological and epigenetic levels.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"059f162f-07ad-5fb2-9577-455db4dbaf80","mechanism_event_label":"It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained.","subject":{"id":"3df322fd-ac21-5bd1-aa46-4af1ec708b57","slug":"mevalonate","display_name":"Mevalonate","entity_type_key":"small_molecule"},"object":{"id":"ee2482e0-2c55-50ac-8daa-085c11fe397d","slug":"trained-immunity","display_name":"Trained immunity, an altered response to a later challenge after the first has ended","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"059f162f-07ad-5fb2-9577-455db4dbaf80","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-mevalonate-not-cholesterol-trains-event","event_type":"biochemical_relationship","label":"It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained.","description":"Activation of the cholesterol synthesis pathway but not the synthesis of cholesterol itself is essential for training of myeloid cells, rather the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways, statins which block mevalonate generation prevent trained immunity induction, and monocytes of patients with hyper immunoglobulin D syndrome who are mevalonate kinase deficient and accumulate mevalonate have a constitutive trained immunity phenotype at both immunological and epigenetic levels.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8d038691-634e-5ef7-afdd-f70337ae0b67","slug":"cholesterol-synthesis-pathway","display_name":"The cholesterol synthesis pathway","entity_type_key":"cellular_process"},"role":"host_pathway","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"d3a1b93d-0a2c-5d1b-b672-5e4ef4b09a10","slug":"cholesterol","display_name":"Cholesterol","entity_type_key":"lipid"},"role":"noncausal_product","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d240f5b5-d225-5f4a-ab28-8070ccb52870","slug":"igf1r","display_name":"Human insulin-like growth factor 1 receptor / IGF1R","entity_type_key":"protein"},"role":"required_receptor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"779b2149-a16f-58b8-815b-7f1f2620da1f","slug":"mtor","display_name":"Human mechanistic target of rapamycin kinase / MTOR","entity_type_key":"protein"},"role":"required_kinase","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"3a5a3d3a-0d50-5b2e-9108-6440324d2de8","slug":"hyper-igd-syndrome","display_name":"Hyper-immunoglobulin D syndrome with mevalonate kinase deficiency","entity_type_key":"cellular_process"},"role":"natural_experiment","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"dca88fca-981a-5a11-8a73-997d334bf9d4","slug":"monocyte","display_name":"Monocyte","entity_type_key":"cell_type"},"role":"trained_cell","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"3df322fd-ac21-5bd1-aa46-4af1ec708b57","slug":"mevalonate","display_name":"Mevalonate","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"ee2482e0-2c55-50ac-8daa-085c11fe397d","slug":"trained-immunity","display_name":"Trained immunity, an altered response to a later challenge after the first has ended","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/glucan-research/29328908.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03\", \"start_char\": 0, \"end_char\": 1173, \"text_sha256\": \"c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Training of myeloid cells with statins to block mevalonate generation, and monocytes from mevalonate kinase deficient patients","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The patient arm is a natural experiment in the opposite direction, which is what makes the mevalonate assignment convincing. The statin result is inhibition of an induced laboratory response.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.","comparator":null,"unit":null,"notes":"","entity":{"slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[bg-p29328908] Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29328908/ DOI: 10.1016/j.cell.2017.11.025","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Monocyte","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"0f519484-0ac9-5e2b-98a1-cddc4cab2b58","evidence_kind":"source_excerpt","locator":"Lines 463-474","start_line":463,"end_line":474,"excerpt":"### bg-mevalonate-not-cholesterol-trains\nActivation of the cholesterol synthesis pathway but not the synthesis of cholesterol itself is essential for training of myeloid cells, rather the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways, statins which block mevalonate generation prevent trained immunity induction, and monocytes of patients with hyper immunoglobulin D syndrome who are mevalonate kinase deficient and accumulate mevalonate have a constitutive trained immunity phenotype at both immunological and epigenetic levels.\nCondition category: normal\nnutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.\nplain_language: It is the intermediate and not the cholesterol that does the training, and people who cannot clear that intermediate are permanently trained.\norganism: Human\ntissue_or_cell_type: Monocyte\nexperimental_model: Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate\nlimitations: The patient arm is a natural experiment in the opposite direction, which is what makes the mevalonate assignment convincing. The statin result is inhibition of an induced laboratory response.\nexposure: Training of myeloid cells with statins to block mevalonate generation, and monocytes from mevalonate kinase deficient patients\nevidence_span: {\"source_cache\": \"artifacts/glucan-research/29328908.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03\", \"start_char\": 0, \"end_char\": 1173, \"text_sha256\": \"c7d8052926f6be1dad87fedf0023f60ac5441b04f9b8e180c4b1e07edc83eb03\"}\n[bg-p29328908] Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29328908/ DOI: 10.1016/j.cell.2017.11.025","model_system":"Pharmacological and genetic dissection of the cholesterol synthesis pathway, with monocytes from patients accumulating mevalonate","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [bg-p29328908] Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018). https://pubmed.ncbi.nlm.nih.gov/29328908/ DOI: 10.1016/j.cell.2017.11.025","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"74dc223d-8289-57bf-a731-d220fa017c1e","stable_key":"import-10629adf-a816-5b7b-82db-a76bfbb946f2","title":"Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"7c62f2d2f8d99b650e6dc26a505b0f053ae1c8bdb38099d4dfc0771f65287461","revision_id":"a53bb794-0a4b-525d-9cf7-22b46a5403b0","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}